Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Frontier Biotechnologies Inc banner
F

Frontier Biotechnologies Inc
SSE:688221

Watchlist Manager
Frontier Biotechnologies Inc
SSE:688221
Watchlist
Price: 22.6 CNY -1.35% Market Closed
Market Cap: ¥8.5B
Write Note Create Alert Ask AI

Frontier Biotechnologies Inc
Investor Relations

Frontier Biotechnologies, Inc. engages in the research and development, production, and sale of medicines. The company is headquartered in Nanjing, Jiangsu and currently employs 495 full-time employees. The company went IPO on 2020-10-28. The firm's products include Aikening and Combination regiment of Albuvirtide (ABT) + 3BNC117 which is during clinical stage for treatment of human immunodeficiency virus (HIV). Its clinical-stage products also include transdermal analgesic patch AB001 for treating muscle, skeleton and joint pain. The firm conducts its businesses within the China market and to overseas markets.

Show more
Loading
688221
Shanghai Composite
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Qi Shao
Senior VP & CFO
No Bio Available
Dr. Rongjian Lu Ph.D.
CTO & Director
No Bio Available
Ms. Yuting Zhu
Supervisor & Deputy GM Administrative Director
No Bio Available
Mr. Hangzhou Lv
Senior Vice President of Marketing & Sales
No Bio Available
Ms. Qianya Gao
Deputy GM & Secretary of the Board of Directors
No Bio Available
Dr. Dong Xie Ph.D.
Founder, Chairman & Chief Scientific Officer
No Bio Available
Dr. Changjin Wang Ph.D.
MD, CEO & Director
No Bio Available
Ms. Xiao Hong Zheng Ph.D.
Chief Operating Officer
No Bio Available
Michael Hu
C.M.O.
No Bio Available

Contacts

Address
JIANGSU
Nanjing
11F, Building E-2, Greenland Window, Dongshan Communtiy, Jiangning District
Contacts
+862569648375
www.frontierbiotech.com
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.